Clovis Oncology (CLVS) agreed with Pfizer (PFE) to defer payments for its rucaparib ovarian cancer drug late Tuesday.
Cramer says CyberArk Software is doing well but he's avoiding Clovis Oncology.
Cramer says he doesn't understand the obsession some investors have with the Federal Reserve. Forget the Fed.
Here's a technical look at how to trade some of the most active stocks on the market right now.